Kata K Gyulay

Dr. Kata K Gyulay

Medical Imaging Centre, Semmelweis University, Budapest, Hungary
+1
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KGKata K Gyulay
Kata K Gyulay
PKPéter Karászi
Péter Karászi
MRMátyás Rédei
Mátyás Rédei
Petra SólymosPetra Sólymos
Petra Sólymos
KSKároly Schandl
Károly Schandl
DHDenes B. Horvathy
Denes B. Horvathy
We have previously reported that serum albumin-coated bone allograft (BoneAlbumin, BA) is an effective bone substitute. It improves bone regeneration at the patellar and tibial donor sites six months after harvesting bone-patellar tendon-bone (BPTB) autografts for primary anterior cruciate ligament reconstruction (ACLR). In the present study, we examined these donor sites seven years after implantation. The study group (N = 10) received BA-enhanced autologous cancellous bone at the tibial and BA alone at the patellar site. The control group (N = 16) received autologous cancellous bone at the tibial and blood clot at the patellar site. We evaluated subcortical density, cortical thickness, and bone defect volume via CT scans. At the patellar site, subcortical density was significantly higher in the BA group at both time points. There was no significant difference in cortical thickness between the two groups at either donor site. The control group’s bone defect significantly improved and reached the BA group’s values at both sites by year seven. Meanwhile, the bone defects in the BA group did not change significantly and were comparable to the six-month measurements. No complications were observed. There are two limitations in this study: The number of patients recruited is small, and the randomization of the patients could have improved the quality of the study as the control group patients were older compared to the study group patients. Our 7-year results seem to demonstrate that BA is a safe and effective bone substitute that supports faster regeneration of donor sites and results in good-quality bone tissue at the time of ACLR with BPTB autografts. However, studies with a larger number of patients are required to definitively confirm the preliminary results of our study.

1 January 2019 in Artery Research
Verified
Journal Article
Open access
PDF file
DTDavid Laszlo Tarnoki
David Laszlo Tarnoki
HSHelga Szabo
Helga Szabo
KGKata K Gyulay
Kata K Gyulay
ZJZsofia Jokkel
Zsofia Jokkel
RDRebeka Debreceni
Rebeka Debreceni
ATAdam Domonkos Tarnoki
Adam Domonkos Tarnoki

1 January 2019 in Artery Research
Verified
Journal Article
Open access
PDF file
ATAdam Domonkos Tarnoki
Adam Domonkos Tarnoki
RDRebeka Debreceni
Rebeka Debreceni
GJGreta Janositz
Greta Janositz
KGKata K Gyulay
Kata K Gyulay
JZJokkel Zsofia
Jokkel Zsofia
DTDavid Laszlo Tarnoki
David Laszlo Tarnoki